Skip to main content
Premium Trial:

Request an Annual Quote

Trust Sanger Institute, Bacterial BarCodes, Applied Biosystems


Sanger Buys an Illumina Genotyping System

The Wellcome Trust Sanger Institute has bought one of Illumina’s SNP-genotyping labs. The British center will use the gargantuan system for large genotyping projects, including the International HapMap project, Illumina said Feb. 18.

The Wellcome Trust Sanger Institute is the second node of the International HapMap project to purchase an Illumina genotyping system. Genome Quebec, which is conducting genotyping for Genome Canada’s portion of the HapMap, purchased a system Jan. 9.

The system costs between $1.5 million and $2 million and comprises Sherlock scanning equipment, Golden Gate assay protocols, LIMS and analytical software, fluid-handling robotics, and access to Sentrix array matrices and reagent supply. When installed, the lab will be able to crank out one million genotypes per day.

Bacterial BarCodes Pockets $6M Financing

Houston, Texas, startup Bacterial BarCodes has secured $6 million in additional funding in its Series C financing round, the company said last week. Techxas Ventures led the financing.

Bacterial BarCodes is commercializing technology for microbial strain typing and identification systems.

And the Winner of Best Narcissistic Grant is ...

Applied Biosystems will award $250,000 worth of its own SNP-genotyping products to the winner of a grant program it organized, the Applera unit said Feb. 13.

Proposals from individuals, institutions, and companies involved in SNP genotyping are welcome. The winner will be chosen by a panel comprising ABI officials and others, and will be able to choose from ABI’s SNP product line. Apply here:

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.